Publication | Open Access

RETRACTED: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas

Hematological MalignancyTumor BiologyLymphoid NeoplasiaMedicineImmunologyMyc-mediated Mir-29PathologyCancer BiologyCoordinated SilencingHistone ModificationOncologyCancer Research